receptor
porcin
sapeloviru
psv
caus
diarrhea
pneumonia
polioencephalomyel
reproduct
disord
pig
remain
larg
unknown
given
preced
picornavirus
use
termin
sialic
acid
sa
receptor
examin
role
sa
psv
bind
infect
use
varieti
approach
includ
treat
cell
carbohydratedestroy
chemic
naio
monoor
oligosaccharid
nacetylneuramin
acid
galactos
linkagespecif
sialidas
neuraminidas
sialidas
lectin
maakia
amurensi
lectin
sambucu
nigra
lectin
proteas
trypsin
chymotrypsin
glucosylceramid
synthas
inhibitor
phospholipas
c
demonstr
psv
could
recogn
sa
glycolipid
receptor
hand
psv
bind
affin
synthet
histoblood
group
antigen
hbga
suggest
psv
could
use
hbga
receptor
deplet
cell
surfac
glycolipid
follow
reconstitut
studi
indic
gangliosid
gangliosid
could
restor
psv
bind
infect
confirm
sa
psv
receptor
result
could
provid
signific
inform
understand
life
cycl
sapeloviru
picornavirus
broader
commun
area
pathogen
pathogenesi
find
insight
could
contribut
develop
afford
use
effici
drug
antisapeloviru
therapi
porcin
sapeloviru
psv
known
caus
enter
pneumonia
polioencephalomyel
reproduct
disord
pig
howev
receptor
psv
util
enter
host
cell
remain
larg
unknown
use
varieti
approach
show
termin
sialic
acid
sa
cell
surfac
gangliosid
could
use
psv
bind
infect
receptor
hand
histoblood
group
antigen
also
present
cell
surfac
carbohydr
could
util
psv
receptor
bind
infect
find
contribut
understand
sapeloviru
life
cycl
develop
afford
use
effici
drug
antisapeloviru
therapi
porcin
sapeloviru
use
sialic
acid
gangliosid
receptor
v
iral
infect
initi
bind
viru
particl
specif
receptor
surfac
host
cell
monosaccharid
sialic
acid
sa
larg
famili
neuramin
acid
deriv
decor
eukaryot
cell
surfac
usual
termini
glycan
attach
glycoprotein
glycosphingolipid
proteoglycan
keratin
sulfat
sinc
sa
cell
surfac
readili
access
sa
often
serv
receptor
signific
number
envelop
nonenvelop
virus
repres
least
nine
differ
viru
famili
use
sa
receptor
picornavirida
calicivirida
orthomyxovirida
paramyxovirida
coronavirida
reovirida
parvovirida
polyomavirida
adenovirida
sa
viru
receptor
termin
sa
attach
underli
sugar
chain
linkag
linkag
may
contribut
viru
tissu
tropism
pathogenesi
host
specif
virus
within
picornavirida
famili
small
nonenvelop
virus
contain
singlestrand
positivesens
rna
genom
picornavirus
caus
rang
infect
includ
intestin
respiratori
neurolog
cardiac
hepat
mucocutan
system
diseas
variou
sever
human
anim
porcin
sapeloviru
psv
appear
close
relat
simian
picornaviru
type
simian
sapeloviru
duck
picornaviru
avian
sapeloviru
simian
avian
porcin
picornavirus
recent
assign
member
new
picornaviru
genu
sapeloviru
psv
infect
field
experiment
infect
oral
inocul
pig
may
caus
either
asymptomat
symptomat
infect
latter
case
infect
associ
wide
spectrum
disord
includ
diarrhea
pneumonia
polioencephalomyel
reproduct
disord
pig
speci
known
natur
suscept
psv
although
pregnant
guinea
pig
experiment
infect
psv
develop
placent
lesion
transmiss
psv
primarili
fecalor
rout
aerosol
infect
may
lead
lung
infect
psv
readili
cultiv
cell
cultur
porcin
origin
includ
primari
secondari
pig
kidney
cell
cultur
pig
kidney
cell
line
among
cell
line
speci
psv
replic
babi
hamster
kidney
cell
line
human
cervic
cancer
hela
african
green
monkey
kidney
vero
cell
line
psv
isol
fece
healthi
diarrheic
pig
central
nervou
system
pig
polioencephalomyel
pig
lung
tissu
pneumonia
tissu
stillborn
abort
mummifi
fetus
psv
induc
uniqu
type
ii
cytopath
effect
cpe
character
pyknot
nuclei
highli
granular
eosinophil
cytoplasm
uneven
protrus
coverslip
cultur
stain
hematoxylin
eosin
although
psv
believ
import
pathogen
due
wide
distribut
high
preval
receptor
psv
member
genu
sapeloviru
remain
larg
unknown
larg
number
virus
includ
sever
picornavirus
use
sa
receptor
therefor
object
studi
determin
whether
psv
could
recogn
sa
receptor
porcin
kidney
llcpk
human
cervic
cancer
hela
cell
american
type
cultur
collect
atcc
maintain
eagl
minim
essenti
medium
emem
supplement
fetal
bovin
serum
fb
uml
penicillin
gml
streptomycin
crandallrees
felin
kidney
crfk
cell
human
lung
fibroblast
madindarbi
canin
kidney
mdck
cell
atcc
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fb
uml
penicillin
gml
streptomycin
cell
atcc
cultur
alpha
minimum
essenti
medium
supplement
fb
uml
penicillin
gml
streptomycin
psv
strain
use
studi
isol
llcpk
cell
diarrheic
fecal
sampl
piglet
south
korea
strain
passag
eight
time
llcpk
cell
includ
isol
adapt
tripl
plaqu
purif
isol
virus
confirm
psv
immunofluoresc
assay
ifa
revers
transcriptionpcr
transmiss
electron
microscopi
human
influenza
viru
apuerto
atcc
propag
mdck
cell
strain
felin
caliciviru
fcv
atcc
propag
crfk
cell
human
rotaviru
rv
strain
wa
atcc
propag
cell
enteroviru
strain
atcc
propag
cell
coxsackieviru
nanci
strain
atcc
propag
hela
cell
reagent
antibodi
trypsin
chymotrypsin
sigmaaldrich
sodium
period
naio
sigmaaldrich
nacetylneuramin
acid
nana
fluka
genechem
galactos
gal
sigmaaldrich
maackia
amurensi
lectin
mal
sigmaaldrich
sambucu
nigra
lectin
snl
sigmaaldrich
dissolv
phosphatebuff
salin
pb
ph
alexa
fluor
succinimidyl
ester
purchas
molecular
probe
catalog
number
dissolv
dimethyl
sulfoxid
dmso
pdmp
calbiochem
phospholipas
c
plc
calbiochem
dissolv
ethanol
reagent
includ
methioninecystein
perkinelm
neuraminidas
na
sigmaaldrich
sialidas
ss
prozym
follow
antibodi
use
studi
antipsv
capsid
monoclon
antibodi
mab
kindli
provid
dauber
friedrich
loeffler
institut
germani
antifcv
capsid
mab
santa
cruz
biotechnolog
capsid
mab
millipor
capsid
mab
abcam
antirv
protein
mab
median
diagnost
antirv
polyclon
antibodi
fluorescein
isothiocyan
fitc
conjug
goat
antimous
igg
antibodi
santa
cruz
biotechnolog
peroxidaseconjug
goat
antirabbit
igg
antibodi
santa
cruz
biotechnolog
gangliosid
ga
purchas
matreya
lstetrasaccharid
c
lstc
obtain
dextra
biotinconjug
oligosaccharid
includ
lewi
antigen
le
le
b
le
x
le
h
type
type
disaccharid
type
b
disaccharid
type
trisaccharid
type
b
trisaccharid
trisaccharid
sle
sle
x
tetrasaccharid
purchas
glycotech
horseradish
peroxidas
hrp
conjug
streptavidin
obtain
jackson
immunoresearch
lab
cytotox
assay
cytotox
chemic
use
studi
determin
use
tetrazolium
bromid
mtt
assay
briefli
cell
plate
incub
medium
contain
differ
concentr
variou
chemic
h
remov
medium
l
mtt
solut
ad
well
incub
h
co
incub
afterward
l
dmso
read
enzymelink
immunosorb
assay
elisa
reader
optic
densiti
od
measur
nm
percent
cell
viabil
calcul
use
follow
formula
od
sampl
od
blank
od
control
od
blank
nontox
concentr
chemic
use
studi
data
shown
treatment
cell
chemic
metabol
inhibitor
enzym
sodium
period
use
mm
concentr
min
neuraminidas
na
ss
pretreat
mu
mu
h
lectin
mal
snl
use
g
ml
h
proteas
trypsin
chymotrypsin
employ
g
ml
min
metabol
inhibitor
pdmp
plc
use
pretreat
cell
day
min
nana
preincub
mm
h
pretreat
cell
wash
three
time
pb
bind
infect
assay
carri
describ
mock
control
treatment
perform
time
label
virus
methioninecystein
label
virus
methioninecystein
perkinelm
carri
describ
previous
slight
modif
briefli
confluent
monolay
cell
infect
individu
viru
multipl
infect
moi
pfucel
h
medium
replac
rpmi
lack
methionin
cystein
sigmaaldrich
cell
starv
h
supplement
mbq
methioninecystein
perkinelm
ml
h
follow
viru
infect
label
viru
purifi
cesium
chlorid
cscl
densiti
gradient
centrifug
describ
viru
purif
cscl
gradient
centrifug
psv
fcv
rv
grown
permiss
cell
line
purifi
cscl
gradient
centrifug
infect
cell
cultur
harvest
h
postinocul
freezethaw
three
time
cell
debri
spun
g
min
total
ml
viruscontain
supernat
concentr
centrifug
g
h
use
rotor
beckman
virus
pellet
resuspend
tne
buffer
mm
trishcl
mm
nacl
mm
edta
ph
suspens
layer
preform
discontinu
cscl
gradient
centrifug
g
h
use
rotor
beckman
band
viru
collect
punctur
side
tube
needl
dilut
distil
water
purifi
ultracentrifug
g
h
rotor
beckman
purifi
virus
dialyz
sodium
bicarbon
buffer
ph
fluoresc
label
tne
buffer
radioact
assay
overnight
store
aliquot
analysi
sdspagesepar
methioninecysteinelabel
viral
particl
radiographi
western
blot
coomassi
blue
stain
show
label
exclus
coupl
viral
capsid
protein
data
shown
plaqu
assay
show
loss
infect
label
viru
permiss
cell
line
comparison
unlabel
viru
data
shown
cscl
gradient
purif
supernat
rv
strain
wainfect
cultur
gener
two
distinct
visibl
band
band
viru
analyz
abovelist
method
viru
purifi
fraction
infecti
tripl
layer
particl
cscl
gradient
centrifug
use
radioact
assay
data
shown
label
virus
label
virus
perform
follow
manufactur
instruct
molecular
probe
purifi
viru
mg
mg
ml
sodium
bicarbon
buffer
ph
label
molar
concentr
succinimidyl
ester
mg
mg
ml
dmso
reaction
mixtur
vortex
thoroughli
incub
h
room
temperatur
continu
stir
fluorophor
react
exclus
free
amin
result
stabl
carboxamid
bond
contain
sevenatom
aminohexanoyl
spacer
x
allow
higher
degre
label
without
function
perturb
viru
label
viru
repurifi
cscl
describ
dialyz
virion
buffer
store
aliquot
analysi
sdspagesepar
viral
particl
coomassi
blue
stain
western
blot
show
label
exclus
coupl
viral
capsid
protein
data
shown
infect
label
viru
determin
plaqu
assay
plaqu
assay
show
loss
infect
label
viru
permiss
cell
line
comparison
unlabel
viru
data
shown
dyelabel
bind
assay
dyelabel
bind
assay
perform
purifi
virus
follow
visual
subcon
fluent
monolay
cell
grown
without
variou
inhibitor
enzym
describ
previous
slight
modif
briefli
mockinfect
treat
cell
inocul
viru
moi
incub
min
ice
follow
incub
room
temperatur
min
cell
wash
extens
cold
pb
fix
formaldehyd
wash
three
time
cold
pb
dish
mount
slowfad
gold
antifad
reagent
invitrogen
contain
dapi
solut
nucleu
stain
infect
cell
observ
lsm
confoc
microscop
analyz
use
lsm
softwar
carl
zeiss
assay
bind
methioninecysteinelabel
virus
variou
cell
line
bind
methioninecysteinelabel
virus
variou
cell
line
assay
describ
previous
slight
modif
briefli
cell
plate
plate
purifi
methioninecysteinelabel
virus
cpm
incub
cell
min
ice
cell
wash
three
time
icecold
pb
follow
cell
lysi
sodium
dodecyl
sulfat
naoh
total
radioact
cell
lysat
determin
liquid
scintil
count
infect
assay
infect
assay
viru
cell
carri
describ
previous
slight
modif
briefli
confluent
monolay
cell
confoc
dish
treat
variou
inhibitor
enzym
describ
mock
treat
cell
infect
viru
moi
pfucel
incub
h
cell
wash
three
time
pb
mainten
medium
ad
cell
incub
h
fcv
h
nanci
h
rv
wa
psv
prior
fix
formaldehyd
pb
analyz
immunofluoresc
assay
describ
immunofluoresc
assay
immunofluoresc
assay
perform
previous
report
slight
modif
briefli
fix
cell
confoc
dish
permeabil
addit
triton
incub
room
temperatur
min
wash
pb
contain
newborn
calf
serum
pbsnc
antipsv
capsid
dilut
antifcv
capsid
dilut
capsid
dilut
antirv
protein
dilut
mab
ad
chamber
slide
incub
overnight
cell
wash
three
time
pbsnc
fitcconjug
secondari
antibodi
dilut
ad
nuclei
stain
propidium
iodid
cell
examin
use
confoc
microscopi
synthet
hbga
bind
assay
synthet
oligosaccharidebas
histoblood
group
antigen
hbga
bind
assay
carri
describ
previous
slight
modif
briefli
plate
coat
virus
viral
protein
synthet
oligosaccharidepolyacrylamidebiotin
conjug
block
solut
bovin
serum
albumin
pb
ph
ad
well
bound
oligosaccharid
block
solut
detect
use
horseradish
peroxidaseconjug
streptavidin
signal
intens
visual
tmb
komabiotech
absorb
read
nm
plate
reader
step
plate
incub
h
wash
five
time
pbstween
gangliosid
deplet
replet
assay
gangliosid
deplet
replet
assay
perform
describ
previous
slight
modif
briefli
cell
plate
chamber
slide
pretreat
serumfre
medium
h
contain
pdmp
mu
plc
dissolv
dmso
mock
treat
equal
amount
dmso
h
prior
infect
free
gangliosid
lstc
ad
medium
medium
contain
inhibitor
gangliosid
replac
everi
h
prior
infect
cell
infect
harvest
describ
clone
express
purif
rotaviru
p
domain
human
noroviru
human
rv
strain
p
genotyp
p
particl
human
noroviru
nv
strain
clone
express
purifi
describ
previous
concentr
purifi
rv
nv
p
domain
determin
measur
absorb
nm
statist
analysi
statist
analysi
perform
spss
version
window
spss
usa
oneway
analysi
varianc
anova
use
determin
statist
signific
p
determin
whether
psv
could
requir
carbohydr
bind
infect
carbohydr
moieti
remov
cell
naio
destroy
carbohydr
group
without
alter
protein
membran
pretreat
llcpk
cell
variou
concentr
naio
markedli
reduc
bind
psv
strain
refer
simpli
psv
dosedepend
manner
fig
confirm
specif
naio
treatment
use
fcv
could
util
termin
sa
receptor
neg
control
use
use
decayacceler
factor
daf
receptor
expect
pretreat
cell
naio
reduc
bind
carbohydratedepend
fcv
dosedepend
manner
effect
bind
dafdepend
data
shown
accur
quantifi
effect
naio
treatment
radioisotopelabel
viru
incub
cell
pretreat
naio
viru
bind
determin
liquid
scintil
count
treatment
cell
mm
naio
reduc
psv
bind
level
mocktreat
cell
wherea
mm
naio
reduc
bind
fig
expect
naio
treatment
also
result
reduct
fcv
bind
effect
bind
observ
fig
psv
infect
also
reduc
level
cell
pretreat
mm
mm
naio
respect
fig
similar
reduct
infect
observ
naio
treat
cell
infect
known
carbohydratebind
virus
fcv
although
effect
seen
dafbind
fig
data
indic
carbohydr
moieti
requir
bind
infect
psv
hbga
use
psv
attach
calicivirus
rotavirus
known
use
either
sa
hbga
receptor
examin
whether
psv
could
use
hbga
receptor
present
cell
surfac
perform
synthet
hbga
bind
assay
use
psv
particl
variou
virus
specif
control
p
domain
nv
strain
human
influenza
viru
strain
rv
strain
four
strain
psv
show
bind
synthet
hbga
wherea
control
virus
strongli
bound
correspond
hbga
molecul
fig
data
indic
psv
bind
affin
hbga
receptor
sa
act
receptor
psv
sa
abund
carbohydr
moieti
cell
surfac
act
receptor
mani
virus
fcv
porcin
sapoviru
psav
cowden
strain
known
recogn
termin
sa
receptor
among
variou
sa
howev
bind
virus
block
monosaccharid
nana
monosaccharid
gal
oligosaccharid
examin
whether
sa
could
act
receptor
psv
variou
concentr
mm
monosaccharid
gal
nana
oligosaccharid
incub
radiolabel
psv
control
virus
analyz
impact
viru
bind
infect
psv
bind
reduc
nana
dosedepend
manner
fig
b
expect
bind
sadepend
fcv
significantli
block
nana
wherea
bind
ing
daf
receptordepend
unaffect
fig
solubl
nana
also
significantli
decreas
infect
psv
fcv
fig
contrast
preincub
gal
inhibitori
effect
bind
infect
psv
fcv
regardless
concentr
use
fig
data
shown
collect
result
demonstr
psv
like
fcv
could
recogn
sa
receptor
sa
use
psv
attach
infect
sa
typic
link
galactos
terminu
oligosaccharid
either
bond
case
intern
sa
bond
confirm
role
sa
examin
natur
linkag
requir
psv
bind
infect
cell
pretreat
na
vibrio
cholera
cleav
sa
underli
glycan
ss
streptococcu
pneumonia
cleav
sa
pretreat
cell
na
significantli
reduc
bind
radiolabel
psv
sadepend
fcv
well
compar
mocktreat
cell
fig
b
na
also
inhibit
infect
cell
psv
fcv
dafreceptor
depend
fig
pretreat
cell
ss
reduc
bind
infect
psv
fig
expect
ss
treatment
significantli
reduc
bind
use
sa
receptor
effect
bind
infect
sadepend
fcv
dafdepend
fig
data
indic
psv
requir
sa
bind
infect
confirm
abovedescrib
result
effect
lectin
preincub
viru
bind
infect
examin
cell
pretreat
either
mal
preferenti
bind
sa
snl
preferenti
bind
sa
bind
infect
psv
significantli
inhibit
mal
wherea
snl
effect
fig
contrast
bind
infect
fcv
dose
depend
block
snl
mal
fig
expect
mal
snl
affect
bind
infect
dafdepend
fig
collect
data
indic
psv
use
sa
moieti
bind
infect
glycolipidlink
sa
requir
psv
bind
infect
sa
attach
glycoprotein
glycosphingolipid
surfac
permiss
cell
human
rv
strain
wa
use
glycosphinogolipidcontain
sa
moieti
receptor
wherea
fcv
recogn
glycoprotein
contain
sa
moieti
receptor
defin
natur
psv
receptor
llcpk
cell
pretreat
pdmp
plc
inhibit
synthesi
remov
sacontain
glycolipid
pretreat
cell
pdmp
plc
markedli
reduc
psv
bind
infect
fig
bind
infect
pretreat
cell
rv
also
reduc
effect
bind
infect
fcv
observ
fig
examin
psv
bind
could
requir
sacontain
glycoprotein
moieti
cell
pretreat
trypsin
chymotrypsin
proteas
examin
effect
psv
rv
bind
infect
pretreat
trypsin
chymotrypsin
effect
bind
infect
psv
glycolipiddepend
rv
strain
wa
fig
howev
bind
infect
fcv
markedli
reduc
proteas
fig
data
indic
psv
requir
sabear
glycolipid
receptor
act
receptor
psv
determin
gangliosid
use
psv
bind
infect
cell
surfac
gangliosid
deplet
pmdp
pretreat
subsequ
reconstitut
addit
variou
free
gangliosid
includ
ga
lstc
gangliosid
possess
one
termin
sa
gangliosid
termin
sa
without
intern
sa
lstc
contain
one
termin
sa
reconstitut
gangliosid
cell
follow
pmdp
treatment
reveal
psv
bind
infect
llcpk
cell
could
restor
fig
other
data
shown
pdmp
treatment
reduc
bind
infect
psv
level
observ
mocktreat
cell
fig
decreas
bind
infect
rescu
addit
fig
gangliosid
data
shown
bind
infect
control
rv
strain
wa
use
receptor
also
restor
addit
fig
gangliosid
data
shown
data
suggest
psv
bind
termin
intern
sa
moieti
sa
moieti
could
interfer
bind
psv
virus
initi
infect
bind
specif
receptor
surfac
suscept
host
cell
mani
virus
receptor
glycan
carbohydr
link
either
protein
lipid
carbohydr
major
compon
cell
surfac
extracellular
matrix
interact
virus
host
cell
receptor
key
factor
regul
viral
tropism
pathogenesi
host
rang
despit
recognit
sapelovirus
emerg
porcin
simian
avian
pathogen
natur
receptor
use
member
within
genu
sapeloviru
determin
demonstr
psv
use
sa
glycolipid
bind
infect
sa
carbohydr
ubiquit
display
surfac
mammalian
cell
normal
link
underli
sugar
chain
link
galactos
moieti
link
intern
sa
among
virus
within
famili
picornavirida
number
known
use
carbohydr
attach
entri
exampl
equin
rhiniti
viru
theiler
murin
encephalomyel
viru
use
sa
howev
encephalomyocard
viru
member
within
genu
cardioviru
recogn
sa
asid
carbohydr
protein
also
identifi
coreceptor
util
sa
addit
sever
protein
receptor
echovirus
use
heparan
sulfat
show
psv
util
sa
carbohydr
receptor
preincub
monosaccharid
oligosaccharid
significantli
reduc
bind
infect
sadepend
control
virus
fcv
also
psv
cultur
cell
moreov
block
linkag
ss
mal
linkag
snl
prevent
bind
infect
psv
control
linkagdepend
observ
sa
function
psv
attach
host
cell
confirm
import
role
carbohydr
attach
picornavirus
target
cell
cell
surfac
carbohydr
glycan
use
receptor
mani
virus
link
either
protein
lipid
show
deplet
gangliosid
cell
lipid
membran
inhibit
bind
infect
psv
suggest
natur
psv
receptor
form
glycolipid
confirm
glycolipid
specif
recogn
psv
cell
surfac
glycolipid
deplet
specif
gangliosid
reconstitut
cell
membran
reconstitut
cell
membran
deplet
cell
surfac
gangliosid
restor
bind
infect
psv
howev
gangliosid
influenc
psv
bind
infect
taken
togeth
data
show
psv
recogn
termin
sa
glycolipid
receptor
bind
infect
addit
observ
chymotrypsin
trypsin
treatment
cell
effect
viru
infect
suggest
cell
surfaceassoci
protein
play
accessori
role
psv
infect
calicivirus
within
calicivirida
famili
rotavius
reovirida
use
sa
hbga
receptor
attach
cell
find
may
impli
differ
psv
strain
may
use
hbga
termin
sa
receptor
present
studi
howev
four
psv
strain
use
show
bind
hbga
data
specul
least
four
korean
psv
may
util
hbga
receptor
identifi
receptor
genera
noroviru
rotaviru
differ
depend
genotyp
andor
strain
exampl
hbga
act
receptor
human
bovin
norovirus
wherea
termin
sa
function
receptor
murin
noroviru
unlik
neuroinvas
english
psv
strain
caus
sever
nonsuppur
polioencephalomyel
spinal
cord
without
lesion
tissu
korean
psv
strain
enteropathogen
unpublish
data
indic
differ
psv
strain
korea
countri
may
recogn
differ
receptor
conclus
work
demonstr
psv
could
bind
termin
sa
moieti
gangliosid
result
contribut
understand
sapeloviru
life
cycl
pathogenesi
develop
afford
use
effici
drug
antisapeloviru
therapi
